World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6782)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

418

WORD

HTML

4143

Figures (1-1)

481

Tables (1-3)

536

Sum=5662

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

364

Download

756

Sum=1120

Jul 28, 2022 (publication date) through Jan 30, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Li YG, Yu ZJ, Li A, Ren ZG. Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions. World J Gastroenterol 2022; 28(28): 3555-3572 [PMID: 36161048 DOI: 10.3748/wjg.v28.i28.3555]
URL:	https://www.wjgnet.com/1007-9327/full/v28/i28/3555.htm

Number	Citing Articles
1	Mette Munk Lauridsen, Elise Jonasson, Jasmohan S. Bajaj. Microbial Approaches to Treat and Prevent Hepatic Encephalopathy. Gastroenterology Clinics of North America 2025; doi: 10.1016/j.gtc.2024.12.006
2	Qinglan Xia, Yumeng Lei, Jiadun Wang, Qiang Wang. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0741
3	Mohamed Kamel, Sami Aleya, Majed Alsubih, Lotfi Aleya. Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases. Journal of Personalized Medicine 2024; 14(2): 217 doi: 10.3390/jpm14020217
4	Aysun Yakut. Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway. World Journal of Gastroenterology 2024; 30(43): 4672-4676 doi: 10.3748/wjg.v30.i43.4672 Abstract(215) \| Core Tip(164) \| Full Article(HTML)(853) \| Full Article with Cover (PDF)-736K(25) \| Audio-1043K(1) \| Peer-Review Report-246K(20) \| Answering Reviewers-31K(22) \| Full Article (PDF)-381K(47) \| Full Article (XML)-59K(19) \| Times Cited (0) \| Total Visits (1576) \| Open
5	Vanessa Stadlbauer. Gastrointestinales Mikrobiom. 2024; : 129 doi: 10.1007/978-3-662-68455-9_11
6	Cyriac Abby Philips, Philip Augustine. Review: Microbial Therapeutics for Liver Disease. Journal of Gastrointestinal Infections 2023; 13(01): 001 doi: 10.1055/s-0043-1768145
7	Gang Wang, Xianli He, Qian Wang. Intratumoral bacteria are an important “accomplice” in tumor development and metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(1): 188846 doi: 10.1016/j.bbcan.2022.188846
8	Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Viral Liver Disease and Intestinal Gut–Liver Axis. Gastrointestinal Disorders 2024; 6(1): 64 doi: 10.3390/gidisord6010005
9	Qiong Wu, Fangsi Zhu, Yu Yao, Luyun Chen, Yijie Ding, Yong Su, Chaoliang Ge. Sini san regulates intestinal flora and short-chain fatty acids to ameliorate hepatocyte apoptosis and relieve CCl4-induced liver fibrosis in mice. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1408459